中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 1
Jan.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(1): 83-88

Characteristics of the composition of intestinal flora in cirrhotic patients with malnutrition

DOI: 10.12449/JCH240115
  • 1.

    The Fifth Clinical College of Henan University of Chinese Medicine，Zhengzhou 450003，China

  • 2.

    Department of Gastroenterology，People’s Hospital of Henan University of Chinese Medicine/People’s Hospital of Zhengzhou，Zhengzhou 450003，China

Research funding:

Henan Medical Science and Technology Research Plan-Provincial Co-construction Project (2018010044)

More Information
  • Corresponding author: MA Yingjie， mayingjie19@sina.com （ORCID： 0000-0002-6692-5992）
  • Received Date: 2023-04-10
  • Accepted Date: 2023-05-03
  • Published Date: 2024-01-23
    Abstract
  •   Objective  To investigate the characteristics of the composition of intestinal flora and the serum level of endotoxin in cirrhotic patients with malnutrition， and to provide new diagnosis and treatment ideas for improving the nutritional status of patients with liver cirrhosis.  Methods  A total of 58 patients with liver cirrhosis who were hospitalized in Department of Gastroenterology， People’s Hospital of Zhengzhou， from March 2021 to November 2022 were enrolled as experimental group （LC group）， and according to the Royal Free Hospital-Nutritional Prioritizing Tool， they were divided into low malnutrition risk group （LC-A group with 28 patients） and moderate/high malnutrition risk group （LC-B group with 30 patients）； 25 individuals who underwent physical examination during the same period of time were enrolled as control group （HC group）. Peripheral blood and feces samples were collected from all subjects. The limulus amebocyte lysate gel method was used to measure the concentration of endotoxin in peripheral blood， and high-throughput sequencing and bioinformatics analysis were used to investigate the characteristics of intestinal flora. The independent-samples t test was used for comparison of normally distributed continuous data between two groups； a one-way analysis of variance was used for comparison between multiple groups， and the least significant difference t-test were used for further comparison between two groups. The Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups， and the Kruskal-Wallis H test was used for comparison between multiple groups. The chi-square test was used for comparison of categorical data between groups. The Spearman test was used for correlation analysis.  Results  There were significant differences between the three groups in the levels of alanine aminotransferase （H=7.054， P<0.05）， gamma-glutamyl transpeptidase （H=9.644， P<0.05）， albumin （Alb） （F=32.768， P<0.05）， total bilirubin （TBil） （H=20.980， P<0.05）， and serum endotoxin （F=108.672， P<0.05）. There was a significant difference in Chao1 index between the three groups （F=5.110， P=0.008） and between the HC group and the LC-B group （P<0.05）. Compared with the HC group， the LC-A group and the LC-B group had significant reductions in Chao1 index and Shannon index， and there was a significant difference in Chao1 index between the HC group and the LC-B group （P<0.05）. At the phylum level， the intestinal flora in each group was mainly composed of Bacteroidota， Firmicutes， Proteobacteria， and Actinobacteriota， accounting for more than 95% of all phyla， and there was a significant difference in the relative abundance of Firmicutes between the HC group and the LC-B group （P<0.05）. Serum endotoxin was significantly negatively correlated with Ruminococcaceae （r=-0.420， P=0.007）， and spirochete was significantly positively correlated with TBil （r=0.419， P=0.007） and was significantly negatively correlated with Alb （r=-0.492， P=0.001）.  Conclusion  There are unique changes in intestinal flora in cirrhotic patients with malnutrition， and differentially expressed flora are associated with endotoxemia. Improving intestinal microecology in liver cirrhosis may help to improve nutritional status.

     

    • FullText(HTML)
  • loading
    • References(29)
  • [1]
    TRAUB J, REISS L, ALIWA B, et al. Malnutrition in patients with liver cirrhosis[J]. Nutrients, 2021, 13( 2): 540. DOI: 10.3390/nu13020540.
    [2]
    PASHAYEE-KHAMENE F, HAJIMOHAMMADEBRAHIM-KETABFOROUSH M, SHAHRBAF MA, et al. Malnutrition and its association with the mortality in liver cirrhosis; a prospective nutritional assessment in two referral centers in Iran[J]. Clin Nutr ESPEN, 2023, 54: 453- 458. DOI: 10.1016/j.clnesp.2023.02.021.
    [3]
    MERLI M, APRILE F. The European Association for the Study of Liver(EASL) nutrition guidelines[J]. Recenti Prog Med, 2021, 112( 2): 103- 109. DOI: 10.1701/3559.35370.
    [4]
    XIAO HJ, HAN T. Prevention and treatment of malnutrition, sarcopenia, and osteoporosis in patients with liver cirrhosis[J]. J Clin Hepatol, 2021, 37( 1): 26- 30. DOI: 10.3969/j.issn.1001-5256.2021.01.006.

    肖慧娟, 韩涛. 肝硬化患者营养不良、肌肉减少症及骨质疏松的防治[J]. 临床肝胆病杂志, 2021, 37( 1): 26- 30. DOI: 10.3969/j.issn.1001-5256.2021.01.006.
    [5]
    STADLBAUER V, KOMAROVA I, KLYMIUK I, et al. Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis[J]. Liver Int, 2020, 40( 4): 866- 877. DOI: 10.1111/liv.14382.
    [6]
    PLAUTH M, BERNAL W, DASARATHY S, et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr, 2019, 38( 2): 485- 521. DOI: 10.1016/j.clnu.2018.12.022.
    [7]
    Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35( 11): 2408- 2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.

    中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35( 11): 2408- 2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
    [8]
    MEYER F, BANNERT K, WIESE M, et al. Molecular mechanism contributing to malnutrition and sarcopenia in patients with liver cirrhosis[J]. Int J Mol Sci, 2020, 21( 15): 5357. DOI: 10.3390/ijms21155357.
    [9]
    CHAPMAN B, SINCLAIR M, GOW PJ, et al. Malnutrition in cirrhosis: More food for thought[J]. World J Hepatol, 2020, 12( 11): 883- 896. DOI: 10.4254/wjh.v12.i11.883.
    [10]
    RACHAKONDA V, BORHANI AA, DUNN MA, et al. Serum leptin is a biomarker of malnutrition in decompensated cirrhosis[J]. PLoS One, 2016, 11( 9): e0159142. DOI: 10.1371/journal.pone.0159142.
    [11]
    BUNCHORNTAVAKUL C. Sarcopenia and frailty in cirrhosis: Assessment and management[J]. Med Clin North Am, 2023, 107( 3): 589- 604. DOI: 10.1016/j.mcna.2022.12.007.
    [12]
    RUIGROK RAAA, WEERSMA RK, VICH VILA A. The emerging role of the small intestinal microbiota in human health and disease[J]. Gut Microbes, 2023, 15( 1): 2201155. DOI: 10.1080/19490976.2023.2201155.
    [13]
    GHOSH G, JESUDIAN AB. Small intestinal bacterial overgrowth in patients with cirrhosis[J]. J Clin Exp Hepatol, 2019, 9( 2): 257- 267. DOI: 10.1016/j.jceh.2018.08.006.
    [14]
    BOJKO M. Causes of sarcopenia in liver cirrhosis[J]. Clin Liver Dis, 2019, 14( 5): 167- 170. DOI: 10.1002/cld.851.
    [15]
    PALMER LB, KUFTINEC G, PEARLMAN M, et al. Nutrition in cirrhosis[J]. Curr Gastroenterol Rep, 2019, 21( 8): 38. DOI: 10.1007/s11894-019-0706-5.
    [16]
    ZENG YB, CHEN SJ, FU Y, et al. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma[J]. J Viral Hepat, 2020, 27( 2): 143- 155. DOI: 10.1111/jvh.13216.
    [17]
    GUO XX, HU N, LIAN XX, et al. Features of intestinal flora imbalance in patients with liver cirrhosis and related driving factors[J]. J Clin Hepatol, 2020, 36( 7): 1527- 1533. DOI: 10.3969/j.issn.1001-5256.2020.07.016.

    郭晓霞, 胡娜, 廉晓晓, 等. 肝硬化患者肠道菌群失调的特征及驱动因子分析[J]. 临床肝胆病杂志, 2020, 36( 7): 1527- 1533. DOI: 10.3969/j.issn.1001-5256.2020.07.016.
    [18]
    KRISS M, HAZLETON KZ, NUSBACHER NM, et al. Low diversity gut microbiota dysbiosis: Drivers, functional implications and recovery[J]. Curr Opin Microbiol, 2018, 44: 34- 40. DOI: 10.1016/j.mib.2018.07.003.
    [19]
    LAI JC, TANDON P, BERNAL W, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American association for the study of liver diseases[J]. Hepatology, 2021, 74( 3): 1611- 1644. DOI: 10.1002/hep.32049.
    [20]
    HAO SS, REN XJ, YUAN LL, et al. Correlation of intestinal microecology to muscle mass loss in patients with liver cirrhosis[J]. J Pract Hepatol, 2020, 23( 4): 462- 466. DOI: 10.3969/j.issn.1672-5069.2020.04.003.

    郝莎莎, 任晓静, 原丽莉, 等. 肝硬化患者肠道微生态与肌量减少的相关性研究[J]. 实用肝脏病杂志, 2020, 23( 4): 462- 466. DOI: 10.3969/j.issn.1672-5069.2020.04.003.
    [21]
    IEBBA V, GUERRIERI F, di GREGORIO V, et al. Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy[J]. Sci Rep, 2018, 8( 1): 8210. DOI: 10.1038/s41598-018-26509-y.
    [22]
    SHAO L, LING ZX, CHEN DY, et al. Disorganized gut microbiome contributed to liver cirrhosis progression: A meta-omics-based study[J]. Front Microbiol, 2018, 9: 3166. DOI: 10.3389/fmicb.2018.03166.
    [23]
    SUNG CM, LIN YF, CHEN KF, et al. Predicting clinical outcomes of cirrhosis patients with hepatic encephalopathy from the fecal microbiome[J]. Cell Mol Gastroenterol Hepatol, 2019, 8( 2): 301- 318.e2. DOI: 10.1016/j.jcmgh.2019.04.008.
    [24]
    PARKER BJ, WEARSCH PA, VELOO ACM, et al. The genus Alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health[J]. Front Immunol, 2020, 11: 906. DOI: 10.3389/fimmu.2020.00906.
    [25]
    BLAAK EE, CANFORA EE, THEIS S, et al. Short chain fatty acids in human gut and metabolic health[J]. Benef Microbes, 2020, 11( 5): 411- 455. DOI: 10.3920/BM2020.0057.
    [26]
    MARTIN-GALLAUSIAUX C, MARINELLI L, BLOTTIÈRE HM, et al. SCFA: Mechanisms and functional importance in the gut[J]. Proc Nutr Soc, 2021, 80( 1): 37- 49. DOI: 10.1017/S0029665120006916.
    [27]
    TYAGI AM, YU MC, DARBY TM, et al. The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression[J]. Immunity, 2018, 49( 6): 1116- 1131.e7. DOI: 10.1016/j.immuni.2018.10.013.
    [28]
    TANDON P, MONTANO-LOZA AJ, LAI JC, et al. Sarcopenia and frailty in decompensated cirrhosis[J]. J Hepatol, 2021, 75( Suppl 1): S147- S162. DOI: 10.1016/j.jhep.2021.01.025.
    [29]
    YAO YQ, YANG YQ, CHEN XR, et al. Visual analysis of knowledge map correlation between cirrhosis and gut microbiota[J]. Chin Med Herald, 2023, 20( 20): 17- 22. DOI: 10.20047/j.issn1673-7210.2023.20.03.

    姚倚琦, 杨雅钦, 陈宣睿, 等. 肝硬化与肠道菌群相关性的知识图谱可视化分析[J]. 中国医药导报, 2023, 20( 20): 17- 22. DOI: 10.20047/j.issn1673-7210.2023.20.03.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (152) PDF downloads(32) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return